You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RPRX Sale Disclosure
Urist Marshall · SEC Form 4 · Filed Jun 25, 2026
Sale
Calculated transaction value
$502.07K
Urist Marshall EVP, Research & Investments
RPRX
Transaction date
Jun 24, 2026
Public filing date
Jun 25, 2026
Filing lag
Filed 1 day later
RPRX daily price context
Close on/before transaction
$54.28
Jun 24, 2026
First close after public filing
$56.23
Jun 26, 2026
30-day return after filing
+4.45%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Ordinary Shares
- Quantity / price
- 9,098 shares @ $55.18
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001838139-26-000020
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$502.07K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Royalty Pharma Plc RPRX Current | Sale | Jun 24, 2026 | $502.07K |